Slippery platelet syndromes in subdural hematoma

Neurocritical Care

Volumn 12, Issue 3, 2010, Pages 375-381

  Akins, Paul Taylor ^a,b   Guppy, Kern Hayden ^a,b   Sahrakar, Kamran ^a,b   Hawk, Mark Wade ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Coagulopathy; Platelet dysfunction; Platelet function assay; Platelets; Subdural hematoma; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; COLLAGEN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANALYZER; ARTICLE; ASSAY; BRAIN HEMORRHAGE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DRUG USE; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; SIDE EFFECT; SUBDURAL HEMATOMA; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION;

AGED; BLOOD PLATELET DISORDERS; BRAIN; BRAIN INJURIES; FEMALE; HEMATOMA, SUBDURAL; HUMANS; MALE; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955096879     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9336-3     Document Type: Article

References (21)

1. Konig SA, Schick U, Dohnert J, goldammer A, Vitzthum HE. Coagulopathy and outcome in patients with chronic subdural haematoma. Acta Neurol Scand. 2003;107:110-116
2. Panicker JN, Pavithran K, Thomas M. Management of subdural hematoma in immune thrombocytopenic purpura: report of seven patients and a literature review. Clin Neurol Neurosurg. 2009; 111:189-192
3. Leonard A, Shapiro FL. Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med. 1975;82:650-658
4. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30:579-589
5. Nekludov M, Bellander BM, Blomback M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007;24:1699-1706
6. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51:639-647
7. Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke. 2009;40:2398-2401
8. Naidech AM, Bassin SL, Bernstein RA, Batjer HH, Alberts MJ, Lindholm PF, Bleck TP. Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage. Neurocrit Care. 2009 Apr 21. [Epub ahead of print].
9. Alberts M, Bergman DL, Molner E, Jovanovic BD, Ushiwata I, Teruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease. Stroke. 2004;35:175-178
10. Goldenberg NA, Jacobson L, Manco-Johnson MJ. Brief communication: duration of platelet dysfunction after a 7-day course of ibuprofen. Ann Intern Med. 2005;142:506-509
11. Ng KF, Lawmin JC, Li CC, Tsang SF, Tang WM, Chiu KY. Comprehensive preoperative evaluation of platelet function in total knee arthroplasty patients taking diclofenac. J Arthroplast. 2008;23:424-440
12. Rice ML. Acute subdural haemotoma associated with von Willebrand's disease: a case report. Aust N Z J Surg. 1982;52:86-88
13. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost. 1995;21(Suppl 2):106-112
14. Matzdorff A. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Semin Thromb Hemostasis. 2005;31: 393-399
15. Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost. 2007;5:2393-2398
16. Dickinson KJ, Troxler M, Homer-Vanniasinkam S. The surgical application of point-of-care haemostasis and platelet function testing. Br J Surg. 2008;95:1317-1330
17. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomized controlled trial. Lancet. 2006;367:1903-1912
18. Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, et al. Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Stroke. 2007;38:874-880
19. Pasa S, Bayan K, Kucukoner M, Tuzun Y, Altintas A, Cil T, et al. The effects of non-steroidal anti-inflammatory drugs on platelet function and severity of upper gastrointestinal haemorrhage. J Thromb Thrombolysis. 2009;28:83-89
20. Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, Vercellotti GM. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. J Lab Clin Med. 1988;112:254-263
21. Cable R, Carlson B, Chambers L, Kolins J, Murphy S, Tilzer L, Vassallo R, Weiss J, Wissel ME. American Red Cross Practice Guidelines for Blood transfusion: A compilation from recent peerreviewed literature.Maryland: AABB Press; 2002, p. 15. http://www.redcrosslife.org/hospital/pdf/tmq20.pdf. Accessed May 1, 2009.